Elsevier

Pharmaceutical Science Advances Template

Write in a clean editor, then format for Pharmaceutical Science Advances in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Pharmaceutical Science Advances format

Pharmaceutical Science Advances is a peer-reviewed journal published by Elsevier, covering Nanoparticle-Based Drug Delivery, Drug Solubulity and Delivery Systems, Advanced Drug Delivery Systems.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, Pharmaceutical Science Advances 12 (2023) 45–58.

Formats any DOI in Pharmaceutical Science Advances style. No sign-up.

Publishes research inNanoparticle-Based Drug Delivery Drug Solubulity and Delivery Systems Advanced Drug Delivery Systems Computational Drug Discovery Methods Autophagy in Disease and Therapy
ISSN2773-2169
Citation impact (2-yr)5.57
h-index17
i10-index27
Total citations916
Open accessYes
Top institutions publishing hereShandong University
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Pharmaceutical Science Advances per year

2
2022
23
2023
23
2024
40
2025

Citation impact of Pharmaceutical Science Advances by publication year

34
2022
367
2023
291
2024
162
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Pharmaceutical Science Advances

The effect of particle size on drug bioavailability in various parts of the body

Zi Hong Mok · 23 Nov 2023

Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small particles are presumably easier to be internalised, yet they are not…

Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management

Kamaljeet, Shamsher Singh, Ghanshyam Das Gupta et al. · 20 Oct 2023

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory loss, cognitive decline, impairment in activities of daily living, and loss of independent function. Cognitive decline and brain shrinkage, particularly hippocampal atrophy, are associated with the accumulation of tau proteins. They cause inflammation, amyloid plaque deposition, neuronal loss, temporofrontal cortex atrophy, aberrant protein fragment…

Natural product databases for drug discovery: Features and applications

Tao Zeng, Jiahao Li, Ruibo Wu · 24 Aug 2024

Natural products (NPs) exhibit diverse chemical structures and biological activities that make them valuable sources for drug discovery. With advancements in computational technology, computation-enabled natural drug discovery is gaining increasing significance, with NP databases playing a pivotal role. In light of this, we first summarize the key features of NP databases, including structural data, property…

Targeted drug conjugates in cancer therapy: Challenges and opportunities

Geng Jia, Yuqi Jiang, Xiaoyang Li · 7 Aug 2024

Traditional chemotherapy is often accompanied by off-target toxicity, resulting in adverse side effects and driving the development of targeted therapies. Targeted drug conjugates (TDCs) typically comprise targeting ligands, such as specific antibodies, peptides, or small molecules, attached to a cytotoxic agent via a chemical linker. In this study, we briefly discussed the molecular aspects of…

Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies

Abdullah Al Shamsh Prottay, Mehedi Hasan Bappi, Md. Showkoth Akbor et al. · 23 Nov 2023

Chronic and severe inflammation results in many diseases and disorders in humans. Currently, available conventional anti-inflammatory drugs have numerous mild-to-severe side effects. Thus, there is a need for safe, effective, affordable, and alternative anti-inflammatory drugs. This study aimed to evaluate the anti-inflammatory effect of sclareol (SCL), a diterpene alcohol that is the principal ingredient in…

Pharmaceutical Science Advances template — frequently asked questions

How do I write a paper in the Pharmaceutical Science Advances format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Pharmaceutical Science Advances template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Pharmaceutical Science Advances use?
Pharmaceutical Science Advances uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, Pharmaceutical Science Advances 12 (2023) 45–58.
Do I need to know LaTeX to submit to Pharmaceutical Science Advances?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready Pharmaceutical Science Advances document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Pharmaceutical Science Advances template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Pharmaceutical Science Advances format with correct headings, figures, tables, and numbered citations.
Who publishes Pharmaceutical Science Advances?
Pharmaceutical Science Advances is a multidisciplinary journal published by Elsevier. DocuGuru's Pharmaceutical Science Advances template matches Elsevier's official submission format.
Can I export a submission-ready Pharmaceutical Science Advances PDF?
Yes — DocuGuru produces a PDF built with the official Pharmaceutical Science Advances template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the Pharmaceutical Science Advances template cost?
You can start writing in the Pharmaceutical Science Advances template for free. Exporting the final submission-ready Pharmaceutical Science Advances PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Pharmaceutical Science Advances template